dijous, 9 de febrer de 2017 · International workshop

International workshop “Translating Colorectal Cancer Research”

Translating Colorectal Cancer Research

IPO-Porto (
Presentat per:
eucolongene (  


Manuel Teixeira (IPO-Porto, Porto, Portugal)
Sergi Castellví-Bel (IDIBAPS, Barcelona, Spain)
Thomas Ried (National Cancer Institute, Bethesda, USA)
Jordi Camps (IDIBAPS, Barcelona, Spain)

Colorectal cancer is a major public health concern, ranking among the leading causes of cancer death in both men and women. Because of this continued burden there is a clear need for improved treatment, and more importantly prevention, of this disease. The word ‘translate’ has its origins in the Latin word translatio, meaning 'to carry across'. Accordingly, translational research is focused on carrying discoveries from the laboratory bench to the bedside of the patient. Nowhere is translational medicine making more spectacular gains for patient welfare than in cancer. This field is rapidly progressing along with the advance in cutting-edge laboratory technologies such as next generation sequencing. This 2-day international workshop aims at providing a dedicated forum for the latest approaches used in colorectal cancer research and its translation into improving patient’s life.